login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
MEDIPHARM LABS CORP (LABS.CA) Stock News
Canada
- TSX:LABS -
CA58504D1006
-
Common Stock
0.065
CAD
-0.01 (-7.14%)
Last: 11/18/2025, 7:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
LABS.CA Latest News, Press Relases and Analysis
All
Press Releases
5 days ago - By: MediPharm Labs Corp.
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
5 days ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
6 days ago - By: MediPharm Labs Corp.
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
6 days ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
9 days ago - By: MediPharm Labs Corp.
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
9 days ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
3 months ago - By: MediPharm Labs Corp.
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
3 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
3 months ago - By: MediPharm Labs Corp.
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
3 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
4 months ago - By: MediPharm Labs Corp.
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
4 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
5 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
5 months ago - By: MediPharm Labs Corp.
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
5 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
5 months ago - By: MediPharm Labs Corp.
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
5 months ago - By: Apollo Technology Capital Corporation
- Mentions:
-
Apollo Capital Wins Proxy Contest at MediPharm Labs
5 months ago - By: MediPharm Labs Corp.
- Mentions:
-
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
5 months ago - By: MediPharm Labs Corp.
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
5 months ago - By: MediPharm Labs Corp.
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
5 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
5 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
5 months ago - By: MediPharm Labs Corp.
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
5 months ago - By: Apollo Technology Capital Corporation
Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis Company
6 months ago - By: Benzinga
- Mentions:
VFF
ROMJ.CA
ROMJ.CA
This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago
6 months ago - By: MediPharm Labs Corp.
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
6 months ago - By: MediPharm Labs Corp.
- Mentions:
-
ROMJ
ROMJ.V.CA
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
6 months ago - By: MediPharm Labs Corp.
- Mentions:
-
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
6 months ago - By: Apollo Technology Capital Corporation
- Mentions:
-
MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital
6 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
6 months ago - By: MediPharm Labs Corp.
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
6 months ago - By: Apollo Technology Capital Corporation
Alleged Securities Fraud at MediPharm Labs Says Apollo Capital
6 months ago - By: MediPharm Labs Corp.
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
6 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
6 months ago - By: Apollo Technology Capital Corporation
- Mentions:
-
Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck’s Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma
6 months ago - By: MediPharm Labs Corp.
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
6 months ago - By: MediPharm Labs Corp.
- Mentions:
-
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
Please enable JavaScript to continue using this application.